Cite
JLX001 Ameliorates Ischemia/Reperfusion Injury by Reducing Neuronal Apoptosis via Down-Regulating JNK Signaling Pathway.
MLA
Zhou, Lin, et al. “JLX001 Ameliorates Ischemia/Reperfusion Injury by Reducing Neuronal Apoptosis via Down-Regulating JNK Signaling Pathway.” Neuroscience, vol. 418, Oct. 2019, pp. 189–204. EBSCOhost, https://doi.org/10.1016/j.neuroscience.2019.08.053.
APA
Zhou, L., Ao, L., Yan, Y., Li, W., Ye, A., Li, C., Shen, W., Liang, B., Xiong-Zhu, & Li, Y. (2019). JLX001 Ameliorates Ischemia/Reperfusion Injury by Reducing Neuronal Apoptosis via Down-Regulating JNK Signaling Pathway. Neuroscience, 418, 189–204. https://doi.org/10.1016/j.neuroscience.2019.08.053
Chicago
Zhou, Lin, Lu-yao Ao, Yun-yi Yan, Wan-ting Li, An-qi Ye, Cheng-yuan Li, Wei-yang Shen, Bing-wen Liang, Xiong-Zhu, and Yun-man Li. 2019. “JLX001 Ameliorates Ischemia/Reperfusion Injury by Reducing Neuronal Apoptosis via Down-Regulating JNK Signaling Pathway.” Neuroscience 418 (October): 189–204. doi:10.1016/j.neuroscience.2019.08.053.